1 – 5 of 5
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
A plain language summary on indirectly comparing bleeding after valoctocogene roxaparvovec gene therapy to bleeding with emicizumab prophylaxis
- Contribution to journal › Article
- 2020
-
Mark
Why classical cytogenetics still matters in acute myeloid leukemia
- Contribution to journal › Debate/Note/Editorial
-
Mark
Genetic risk factors for venous thromboembolism
- Contribution to journal › Scientific review
- 2017
-
Mark
Direct lineage reprogramming : a useful addition to the blood cell research toolbox
- Contribution to journal › Debate/Note/Editorial
- 2014
-
Mark
Factor VIII therapy for hemophilia A: current and future issues
- Contribution to journal › Scientific review
